Xavier Momblona-Hernando

Barcelona, CT, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

A Plastic EMP1+ to LGR5+ Cell State Conversion as a Bypass to KRASG12D Pharmacologic Inhibition in Metastatic Colorectal Cancer.

A Plastic EMP1+ to LGR5+ Cell State Conversion as a Bypass to KRASG12D Pharmacologic Inhibition in Metastatic Colorectal Cancer.

Journal: Cancer discovery

Published: April 23, 2025

TGF-β builds a dual immune barrier in colorectal cancer by impairing T cell recruitment and instructing immunosuppressive SPP1+ macrophages.

TGF-β builds a dual immune barrier in colorectal cancer by impairing T cell recruitment and instructing immunosuppressive SPP1+ macrophages.

Journal: Nature genetics

Published: August 16, 2024

New Potent Inhibitor of Transforming Growth Factor-Beta (TGFβ) Signaling that is Efficacious against Microsatellite Stable Colorectal Cancer Metastasis in Combination with Immune Checkpoint Therapy in Mice.

New Potent Inhibitor of Transforming Growth Factor-Beta (TGFβ) Signaling that is Efficacious against Microsatellite Stable Colorectal Cancer Metastasis in Combination with Immune Checkpoint Therapy in Mice.

Journal: ACS pharmacology & translational science

Published: June 20, 2024

FixNCut: single-cell genomics through reversible tissue fixation and dissociation.

FixNCut: single-cell genomics through reversible tissue fixation and dissociation.

Journal: Genome biology

Published: April 12, 2023

Modeling Biochemical Gradients In Vitro to Control Cell Compartmentalization in a Microengineered 3D Model of the Intestinal Epithelium.

Modeling Biochemical Gradients In Vitro to Control Cell Compartmentalization in a Microengineered 3D Model of the Intestinal Epithelium.

Journal: Advanced healthcare materials

Published: June 16, 2022

Mex3a marks drug-tolerant persister colorectal cancer cells that mediate relapse after chemotherapy.

Mex3a marks drug-tolerant persister colorectal cancer cells that mediate relapse after chemotherapy.

Journal: Nature cancer

Published: April 21, 2022

Long-term platinum-based drug accumulation in cancer-associated fibroblasts promotes colorectal cancer progression and resistance to therapy.

Long-term platinum-based drug accumulation in cancer-associated fibroblasts promotes colorectal cancer progression and resistance to therapy.

Journal: Nature communications

Published: January 25, 2022

Metastatic recurrence in colorectal cancer arises from residual EMP1+ cells.

Metastatic recurrence in colorectal cancer arises from residual EMP1+ cells.

Journal: Nature

Published: December 13, 2021

Nodal-induced L1CAM/CXCR4 subpopulation sustains tumor growth and metastasis in colorectal cancer derived organoids.

Nodal-induced L1CAM/CXCR4 subpopulation sustains tumor growth and metastasis in colorectal cancer derived organoids.

Journal: Theranostics

Published: October 02, 2020

Functional patient-derived organoid screenings identify MCLA-158 as a therapeutic EGFR × LGR5 bispecific antibody with efficacy in epithelial tumors.

Functional patient-derived organoid screenings identify MCLA-158 as a therapeutic EGFR × LGR5 bispecific antibody with efficacy in epithelial tumors.

Journal: Nature cancer

Published: August 10, 2020

Zonation of Ribosomal DNA Transcription Defines a Stem Cell Hierarchy in Colorectal Cancer.

Zonation of Ribosomal DNA Transcription Defines a Stem Cell Hierarchy in Colorectal Cancer.

Journal: Cell stem cell

Published: July 04, 2019

A genome editing approach to study cancer stem cells in human tumors.

A genome editing approach to study cancer stem cells in human tumors.

Journal: EMBO molecular medicine

Published: May 05, 2017

Showing 1-12 of 17

Last Updated: 09/26/2026